These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 25337893)

  • 1. AFFIRM--a multiplexed immunoaffinity platform that combines recombinant antibody fragments and LC-SRM analysis.
    Säll A; Carlsson F; Olsson N; Wingren C; Ohlin M; Persson H; Waldemarson S
    J Proteome Res; 2014 Dec; 13(12):5837-47. PubMed ID: 25337893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of Phage-Based Antibody Fragment Reagents for Affinity Enrichment of Bacterial Immunoglobulin G Binding Proteins.
    Säll A; Sjöholm K; Waldemarson S; Happonen L; Karlsson C; Persson H; Malmström J
    J Proteome Res; 2015 Nov; 14(11):4704-13. PubMed ID: 26452057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Highly multiplexed targeted proteomics using precise control of peptide retention time.
    Gallien S; Peterman S; Kiyonami R; Souady J; Duriez E; Schoen A; Domon B
    Proteomics; 2012 Apr; 12(8):1122-33. PubMed ID: 22577013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a Chip/Chip/SRM platform using digital chip isoelectric focusing and LC-Chip mass spectrometry for enrichment and quantitation of low abundance protein biomarkers in human plasma.
    Rafalko A; Dai S; Hancock WS; Karger BL; Hincapie M
    J Proteome Res; 2012 Feb; 11(2):808-17. PubMed ID: 22098410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-throughput SISCAPA quantitation of peptides from human plasma digests by ultrafast, liquid chromatography-free mass spectrometry.
    Razavi M; Frick LE; LaMarr WA; Pope ME; Miller CA; Anderson NL; Pearson TW
    J Proteome Res; 2012 Dec; 11(12):5642-9. PubMed ID: 23126378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mass spectrometric discovery and selective reaction monitoring (SRM) of putative protein biomarker candidates in first trimester Trisomy 21 maternal serum.
    Lopez MF; Kuppusamy R; Sarracino DA; Prakash A; Athanas M; Krastins B; Rezai T; Sutton JN; Peterman S; Nicolaides K
    J Proteome Res; 2011 Jan; 10(1):133-42. PubMed ID: 20499897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extended Range Proteomic Analysis (ERPA): a new and sensitive LC-MS platform for high sequence coverage of complex proteins with extensive post-translational modifications-comprehensive analysis of beta-casein and epidermal growth factor receptor (EGFR).
    Wu SL; Kim J; Hancock WS; Karger B
    J Proteome Res; 2005; 4(4):1155-70. PubMed ID: 16083266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrated solid-phase extraction-capillary liquid chromatography (speLC) interfaced to ESI-MS/MS for fast characterization and quantification of protein and proteomes.
    Falkenby LG; Such-Sanmartín G; Larsen MR; Vorm O; Bache N; Jensen ON
    J Proteome Res; 2014 Dec; 13(12):6169-75. PubMed ID: 25277625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantifying attomole amounts of proteins from complex samples by nano-LC and selected reaction monitoring.
    Fröhlich T; Arnold GJ
    Methods Mol Biol; 2011; 790():141-64. PubMed ID: 21948412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advancing the immunoaffinity platform AFFIRM to targeted measurements of proteins in serum in the pg/ml range.
    Säll A; Corbee D; Vikström S; Ottosson F; Persson H; Waldemarson S
    PLoS One; 2018; 13(2):e0189116. PubMed ID: 29438379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coupling immunoaffinity techniques with MS for quantitative analysis of low-abundance protein biomarkers.
    Ackermann BL; Berna MJ
    Expert Rev Proteomics; 2007 Apr; 4(2):175-86. PubMed ID: 17425454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tandem affinity depletion: a combination of affinity fractionation and immunoaffinity depletion allows the detection of low-abundance components in the complex proteomes of body fluids.
    Mortezai N; Harder S; Schnabel C; Moors E; Gauly M; Schlüter H; Wagener C; Buck F
    J Proteome Res; 2010 Dec; 9(12):6126-34. PubMed ID: 20839810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective 351 nm photodissociation of cysteine-containing peptides for discrimination of antigen-binding regions of IgG fragments in bottom-up liquid chromatography-tandem mass spectrometry workflows.
    Cotham VC; Wine Y; Brodbelt JS
    Anal Chem; 2013 Jun; 85(11):5577-85. PubMed ID: 23641966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improvement of the performance of targeted LC-MS assays through enrichment of histidine-containing peptides.
    Mesmin C; Domon B
    J Proteome Res; 2014 Dec; 13(12):6160-8. PubMed ID: 25321649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiplexed MRM-based quantitation of candidate cancer biomarker proteins in undepleted and non-enriched human plasma.
    Percy AJ; Chambers AG; Yang J; Borchers CH
    Proteomics; 2013 Jul; 13(14):2202-15. PubMed ID: 23592487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An integrated serum proteomic approach capable of monitoring the low molecular weight proteome with sequencing of intermediate to large peptides.
    Merrell K; Thulin CD; Esplin MS; Graves SW
    Rapid Commun Mass Spectrom; 2009 Sep; 23(17):2685-96. PubMed ID: 19630037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Automated 20 kpsi RPLC-MS and MS/MS with chromatographic peak capacities of 1000-1500 and capabilities in proteomics and metabolomics.
    Shen Y; Zhang R; Moore RJ; Kim J; Metz TO; Hixson KK; Zhao R; Livesay EA; Udseth HR; Smith RD
    Anal Chem; 2005 May; 77(10):3090-100. PubMed ID: 15889897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunoaffinity enrichment and liquid chromatography-selected reaction monitoring mass spectrometry for quantitation of carbonic anhydrase 12 in cultured renal carcinoma cells.
    Rafalko A; Iliopoulos O; Fusaro VA; Hancock W; Hincapie M
    Anal Chem; 2010 Nov; 82(21):8998-9005. PubMed ID: 20936840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The development of SRM assays is transforming proteomics research.
    Manes NP; Nita-Lazar A
    Proteomics; 2017 Apr; 17(7):. PubMed ID: 27718317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent progress in selected reaction monitoring MS-driven plasma protein biomarker analysis.
    Chiu CL; Randall S; Molloy MP
    Bioanalysis; 2009 Jul; 1(4):847-55. PubMed ID: 21083142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.